Your browser doesn't support javascript.
loading
A globally applicable "triple A" risk model for essential thrombocythemia based on Age, Absolute neutrophil count, and Absolute lymphocyte count.
Tefferi, Ayalew; Loscocco, Giuseppe G; Farrukh, Faiqa; Szuber, Natasha; Mannelli, Francesco; Pardanani, Animesh; Hanson, Curtis A; Ketterling, Rhett P; De Stefano, Valerio; Carobbio, Alessandra; Barbui, Tiziano; Guglielmelli, Paola; Gangat, Naseema; Vannucchi, Alessandro M.
Afiliação
  • Tefferi A; Divisions of Hematology and Hematopathology, Mayo Clinic, Rochester, Minnesota, USA.
  • Loscocco GG; Department of Experimental and Clinical Medicine, CRIMM, Center Research, and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy.
  • Farrukh F; Divisions of Hematology and Hematopathology, Mayo Clinic, Rochester, Minnesota, USA.
  • Szuber N; Department of Hematology, Université de Montréal, Quebec, Canada.
  • Mannelli F; Department of Experimental and Clinical Medicine, CRIMM, Center Research, and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy.
  • Pardanani A; Divisions of Hematology and Hematopathology, Mayo Clinic, Rochester, Minnesota, USA.
  • Hanson CA; Divisions of Hematology and Hematopathology, Mayo Clinic, Rochester, Minnesota, USA.
  • Ketterling RP; Divisions of Hematology and Hematopathology, Mayo Clinic, Rochester, Minnesota, USA.
  • De Stefano V; Section of Hematology, Department of Radiological and Hematological Sciences, Catholic University, Rome, Italy.
  • Carobbio A; FROM esearch Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy.
  • Barbui T; FROM esearch Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy.
  • Guglielmelli P; Department of Experimental and Clinical Medicine, CRIMM, Center Research, and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy.
  • Gangat N; Divisions of Hematology and Hematopathology, Mayo Clinic, Rochester, Minnesota, USA.
  • Vannucchi AM; Department of Experimental and Clinical Medicine, CRIMM, Center Research, and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy.
Am J Hematol ; 98(12): 1829-1837, 2023 12.
Article em En | MEDLINE | ID: mdl-37665758
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trombocitemia Essencial Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Middle aged Idioma: En Revista: Am J Hematol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trombocitemia Essencial Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Middle aged Idioma: En Revista: Am J Hematol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos